rs200339565
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PVS1PM2
The NM_001037.5(SCN1B):c.63C>A(p.Cys21*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Synonymous variant affecting the same amino acid position (i.e. C21C) has been classified as Likely benign.
Frequency
Consequence
NM_001037.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001037.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SCN1B | NM_001037.5 | MANE Select | c.63C>A | p.Cys21* | stop_gained | Exon 2 of 6 | NP_001028.1 | ||
| SCN1B | NM_199037.5 | c.63C>A | p.Cys21* | stop_gained | Exon 2 of 3 | NP_950238.1 | |||
| SCN1B | NM_001321605.2 | c.-37C>A | 5_prime_UTR | Exon 2 of 6 | NP_001308534.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SCN1B | ENST00000262631.11 | TSL:1 MANE Select | c.63C>A | p.Cys21* | stop_gained | Exon 2 of 6 | ENSP00000262631.3 | ||
| SCN1B | ENST00000415950.5 | TSL:1 | c.63C>A | p.Cys21* | stop_gained | Exon 2 of 3 | ENSP00000396915.2 | ||
| SCN1B | ENST00000638536.1 | TSL:1 | c.63C>A | p.Cys21* | stop_gained | Exon 2 of 5 | ENSP00000492022.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at